secwatch.observer — SEC 8-K summary
======================================

Issuer:     CITIUS ONCOLOGY, INC. (CTOR)
CIK:        0001851484
Form:       8-K
Filed at:   2025-04-25T23:59:59+00:00
Accession:  0001213900-25-035575
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Citius Oncology receives Nasdaq deficiency notice for bid price below $1.00
---------------------------------------------------------------------------

- Nasdaq notified Citius Oncology that its common stock bid price closed below $1.00 for 30 consecutive business days.
- Company has 180 calendar days (until October 20, 2025) to regain compliance with the Bid Price Rule.
- If stock closes at $1.00 or more for ten consecutive business days, Nasdaq will confirm compliance.
- If not compliant by October 20, 2025, the Company may be eligible for an additional 180-day period, subject to conditions.
- Company is evaluating options, including a potential reverse stock split, to regain compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1851484/000121390025035575/0001213900-25-035575-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1851484/000121390025035575/ea0239433-8k_citius.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-035575

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer